SeaSpine’s First Quarter Growth Fueled by Volume Gains

SeaSpine reported 1Q21 orthopedic revenue of USD $42 million, +16.2% vs. 1Q20. The company pointed to a positive inflection point for surgical volumes in February, with momentum continuing through March and April. SeaSpine’s leadership reported that spinal implant volumes increased +10% for the quarter, the culmination of a robust new product...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us